<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Female Athlete Triad: Cumulative risk assessment</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Female Athlete Triad: Cumulative risk assessment</h1>
<div class="graphic"><div class="figure"><div class="ttl">Female Athlete Triad: Cumulative risk assessment</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1" colspan="2" rowspan="2">Risk factors</td> <td class="subtitle1" colspan="3">Magnitude of risk</td> </tr> <tr> <td class="subtitle2">Low risk<br/> (0 points each)</td> <td class="subtitle2">Moderate risk<br/> (1 points each)</td> <td class="subtitle2">High risk<br/> (2 points each)</td> </tr> <tr> <td class="indent1" colspan="2">Low EA with or without DE/ED</td> <td><span class="primarybox_left"> </span>No dietary restriction</td> <td><span class="primarybox_left"> </span>Some dietary <span style="white-space: nowrap;">restriction*;</span> current or past history of DE</td> <td><span class="primarybox_left"> </span>Meets DSM-V criteria for <span style="white-space: nowrap;">ED<sup>¶</sup></span></td> </tr> <tr> <td class="indent1" colspan="2">Low BMI</td> <td><span class="primarybox_left"> </span>BMI ≥18.5 <strong>or</strong><br/> <span style="white-space: nowrap;">≥90% EW<sup>Δ</sup></span> <strong>or</strong><br/> weight stable</td> <td><span class="primarybox_left"> </span>BMI 17.5 to &lt;18.5 <strong>or</strong><br/> &lt;90% but ≥85% EW <strong>or</strong><br/> 5 to &lt;10% weight loss per month</td> <td><span class="primarybox_left"> </span>BMI &lt;17.5 <strong>or</strong><br/> &lt;85% EW <strong>or</strong><br/> ≥10% weight loss per month</td> </tr> <tr> <td class="indent1" colspan="2">Delayed menarche</td> <td><span class="primarybox_left"> </span>Menarche &lt;15 years</td> <td><span class="primarybox_left"> </span>Menarche 15 to &lt;16 years</td> <td><span class="primarybox_left"> </span>Menarche ≥16 years</td> </tr> <tr> <td class="indent1" colspan="2">Oligomenorrhea and/or amenorrhea</td> <td><span class="primarybox_left"> </span>&gt;9 menses in <span style="white-space: nowrap;">12 months<sup>¶</sup></span></td> <td><span class="primarybox_left"> </span>6 to 9 menses in <span style="white-space: nowrap;">12 months<sup>¶</sup></span></td> <td><span class="primarybox_left"> </span>&lt;6 menses in <span style="white-space: nowrap;">12 months<sup>¶</sup></span></td> </tr> <tr> <td class="indent1" colspan="2">Low BMD</td> <td><span class="primarybox_left"> </span>Z-score &gt;<span style="white-space: nowrap;">–1.0</span></td> <td><span class="primarybox_left"> </span>Z-score <span style="white-space: nowrap;">–1.0<sup>◊</sup></span> to <span style="white-space: nowrap;">–2.0</span></td> <td><span class="primarybox_left"> </span>Z-score &lt;<span style="white-space: nowrap;">–2.0</span></td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="2">Stress reaction/fracture</td> <td><span class="primarybox_left"> </span>None</td> <td><span class="primarybox_left"> </span>1</td> <td><span class="primarybox_left"> </span>≥2 sites; ≥1 high risk or trabecular bone <span style="white-space: nowrap;">site<sup>§</sup></span></td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="5">Cumulative risk (total each column, then add for total score)</td> </tr> <tr class="divider_bottom"> <td style="font-size: 1.2em; text-align: right;"><strong>Total score:</strong></td> <td style="font-size: 1.2em; text-align: right;"><strong>=</strong></td> <td style="font-size: 1.2em; text-align: right;"><strong>+</strong></td> <td style="font-size: 1.2em; text-align: right;"><strong>+</strong></td> <td style="font-size: 1.2em;"> </td> </tr> <tr class="divider_top divider_bottom"> <td class="sublist1 highlight_gray_text" colspan="5"> </td> </tr> <tr> <td class="subtitle2_left" colspan="5">Scoring of risk factors is as follows:</td> </tr> <tr> <td class="indent1"> <ul> <li>0 to 1 </li> </ul> </td> <td>Low risk</td> <td colspan="3">The athlete is cleared for full participation in practice and competition.</td> </tr> <tr> <td class="indent1"> <ul> <li>2 to 5 </li> </ul> </td> <td>Moderate risk</td> <td colspan="3">The athlete may participate to a modified extent, but may not participate fully in practice or competition, and must be monitored closely to be certain their condition is improving.</td> </tr> <tr> <td class="indent1"> <ul> <li>≥6 </li> </ul> </td> <td>High risk</td> <td colspan="3">The athlete may not participate in practice or competition.</td> </tr> <tr> <td colspan="5">For guidance about clinical improvement and clearance for participation, please refer to the UpToDate topic discussing the female athlete triad.</td> </tr> </tbody></table></div><div class="graphic_lgnd">The cumulative risk assessment provides an objective method of determining an athlete's risk using risk stratification and evidence-based risk factors for the Female Athlete Triad.</div><div class="graphic_footnotes">EA: energy availability; DE: disordered eating; ED: eating disorder; DSM-V: Diagnostic and Statistical Manual of Mental Disorders, fifth edition; BMI: body mass index; EW: expected weight; BMD: bone mineral density.<br/>* Some dietary restriction as evidenced by self report or low/inadequate energy intake on diet logs.<br/>¶ History/current history.<br/>Δ ≥90% EW; absolute BMI cutoffs should not be used for adolescents.<br/><font class="lozenge">◊</font> Weight-bearing sport.<br/>§ High-risk skeletal sites associated with low BMD and delay in return to play in athletes with one or more components of the Triad include stress reaction/fracture of trabecular sites (femoral neck, sacrum, pelvis).</div><div class="graphic_reference">Reproduced with permission from: De Souza MJ, Nattiv A, Joy E, et al. 2014 Female Athlete Triad Coalition Consensus Statement on Treatment and Return to Play of the Female Athlete Triad: 1st International Conference held in San Francisco, California, May 2012 and 2nd International Conference held in Indianapolis, Indiana, May 2013. Br J Sports Med 2014; 48(4):289-308. Copyright © 2014 BMJ Publishing Group Ltd.</div><div id="graphicVersion">Graphic 122416 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
